- Home
- XERS vs ROOT Comparison
XERS vs ROOT Comparison
Compare XERS & ROOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$7.92
Company Overview
Basic Information| Metric | XERS | ROOT |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | XERS | ROOT |
|---|---|---|
| Price | $7.92 | $76.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $10.43 | ★ $125.80 |
| AVG Volume (30 Days) | ★ 2.5M | 262.2K |
| Earning Date | 11-06-2025 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 3.34 |
| Revenue | $266,137,000.00 | ★ $1,446,800,000.00 |
| Revenue This Year | $44.37 | $29.96 |
| Revenue Next Year | $27.87 | $5.89 |
| P/E Ratio | ★ N/A | $22.69 |
| Revenue Growth | ★ 42.05 | 38.50 |
| 52 Week Low | $3.14 | $68.08 |
| 52 Week High | $10.08 | $181.14 |
Technical Indicators
Market Signals| Indicator | XERS | ROOT |
|---|---|---|
| Relative Strength Index (RSI) | 59.42 | 51.75 |
| Support Level | $6.88 | $68.12 |
| Resistance Level | $8.42 | $74.54 |
| Average True Range (ATR) | 0.43 | 2.75 |
| MACD | 0.10 | 0.41 |
| Stochastic Oscillator | 70.38 | 87.26 |
Price Performance
Historical Comparison XERS
ROOT
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About ROOT Root Inc.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.